Nagi Bioscience is at the forefront of shaping the future of biological testing. As a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL), they were founded in Switzerland in 2019 with the aim of unlocking the potential of micro-organisms and powerful data points to revolutionize scientific research. Their cutting-edge laboratory equipment offers fully automated high-content screening of substances as an alternative to animal testing.

Nagi Bioscience provides Nagi Assay Kits, Software Solutions, and Service Solutions to enable researchers to conduct early toxicology, pre-clinical testing, aging research, and more. Their innovative Organism-on-Chip technology has been pioneering the field for over a decade. The brand prides itself on the expertise of its multi-disciplinary team, including microsystems expert Dr.

Matteo Cornaglia (CEO and co-founder) and biologist Dr. Laurent Mouchiroud (CSO and co-founder). Together, they have created a microfluidic technology that accelerates research while reducing the reliance on animal testing.

Join Nagi Bioscience in the new era of biological testing and stay connected through their blog, webinars, and social channels. For more information, you can contact them via email or visit their website